http://dbpedia.org/ontology/abstract
|
TopoTarget (Nasdaq Copenhagen: TOPO) was a … TopoTarget (Nasdaq Copenhagen: TOPO) was a Copenhagen-based biotechnology company focused on the discovery and development of drugs and therapies to treat cancer. In 2014, it merged with BioAlliance Pharma and is now part of . It was founded in 2000 by a group of clinicians. TopoTarget was involved in collaborations with both academia and industry. In 2001 they began collaborating with the National Cancer Institute, a component of the US National Institutes of Health. Since their acquisition of , they have been collaborating with the Netherlands Cancer Institute. They also collaborate with Rigshospitalet, the national hospital of Denmark. TopoTarget has also collaborated with other companies, including Novartis since 2003, and Lundbeck as of October 2007; Topotarget has been member of the Danish Innovation Network Biopeople since 2005.h Innovation Network Biopeople since 2005.
|
http://dbpedia.org/ontology/assets
|
5.8541E8
|
http://dbpedia.org/ontology/equity
|
4.1179E8
|
http://dbpedia.org/ontology/foundingYear
|
2000
|
http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chairman_of_the_Board +
, http://dbpedia.org/resource/Chief_Executive_Officer +
, http://dbpedia.org/resource/CFO +
|
http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Denmark +
, http://dbpedia.org/resource/Copenhagen +
|
http://dbpedia.org/ontology/netIncome
|
1.4046E8
|
http://dbpedia.org/ontology/numberOfEmployees
|
68
, 53
|
http://dbpedia.org/ontology/operatingIncome
|
1.3249E8
|
http://dbpedia.org/ontology/revenue
|
4.3979E7
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/TopoTarget_logo.jpg?width=300 +
|
http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
http://dbpedia.org/ontology/wikiPageExternalLink
|
http://molpharm.aspetjournals.org/cgi/content/full/70/5/1503 +
, http://www.topotarget.com +
, https://www.webcitation.org/5h2WGkzc0%3Furl=http:/molpharm.aspetjournals.org/cgi/content/full/70/5/1503 +
, http://www.medicalnewstoday.com/articles/120656.php +
, http://www.biochemj.org/bj/409/bj4090581.htm +
, https://web.archive.org/web/20090705010929/http:/www.bio-medicine.org/biology-technology-1/TopoTarget-Successfully-Buys-Back-Full-Control-of-Belinostat-4752-3/ +
, https://web.archive.org/web/20090705035811/http:/findarticles.com/p/articles/mi_m0HXI/is_2006_Nov_15/ai_n24995868/ +
, http://findarticles.com/p/articles/mi_m0HXI/is_2006_Nov_15/ai_n24995868/ +
, https://web.archive.org/web/20170515221749/http:/www.biochemj.org/bj/409/bj4090581.htm +
, http://www.topotarget.com/ +
, http://www.bio-medicine.org/biology-technology-1/TopoTarget-Successfully-Buys-Back-Full-Control-of-Belinostat-4752-3/ +
|
http://dbpedia.org/ontology/wikiPageID
|
20579288
|
http://dbpedia.org/ontology/wikiPageLength
|
29390
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1094222004
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Skin_diseases +
, http://dbpedia.org/resource/Denmark +
, http://dbpedia.org/resource/Topoisomerase_II +
, http://dbpedia.org/resource/Netherlands_Cancer_Institute +
, http://dbpedia.org/resource/Acne +
, http://dbpedia.org/resource/Cancer +
, http://dbpedia.org/resource/Preclinical +
, http://dbpedia.org/resource/Histone_deacetylase_inhibitor +
, http://dbpedia.org/resource/Nicotinamide_phosphoribosyltransferase +
, http://dbpedia.org/resource/Small_molecule +
, http://dbpedia.org/resource/Recombinant_protein +
, http://dbpedia.org/resource/APMIS +
, http://dbpedia.org/resource/Pro-apoptotic +
, http://dbpedia.org/resource/Dentition +
, http://dbpedia.org/resource/United_Kingdom +
, http://dbpedia.org/resource/Antibody +
, http://dbpedia.org/resource/Lundbeck +
, http://dbpedia.org/resource/Onxeo +
, http://dbpedia.org/resource/Medicinal_chemistry +
, http://dbpedia.org/resource/Valproic_acid +
, http://dbpedia.org/resource/Germany +
, http://dbpedia.org/resource/Fas_receptor +
, http://dbpedia.org/resource/Preclinical_stage +
, http://dbpedia.org/resource/T_cell_lymphoma +
, http://dbpedia.org/resource/CNS_disorders +
, http://dbpedia.org/resource/Category:Companies_listed_on_Nasdaq_Copenhagen +
, http://dbpedia.org/resource/HER2 +
, http://dbpedia.org/resource/Lymphoma +
, http://dbpedia.org/resource/Copenhagen +
, http://dbpedia.org/resource/Paclitaxel +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Ligand +
, http://dbpedia.org/resource/Ovarian_cancer +
, http://dbpedia.org/resource/Portland_Press +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Denmark +
, http://dbpedia.org/resource/Pivotal_trial +
, http://dbpedia.org/resource/New_Drug_Application +
, http://dbpedia.org/resource/Prolifix +
, http://dbpedia.org/resource/Prolifix_Ltd. +
, http://dbpedia.org/resource/Nordic_Business_Report +
, http://dbpedia.org/resource/Anti-cancer +
, http://dbpedia.org/resource/Oxford_University_Hospital +
, http://dbpedia.org/resource/Frankfurt_University_Hospital +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/American_Society_for_Pharmacology_and_Experimental_Therapeutics +
, http://dbpedia.org/resource/G2M_Cancer_Drugs_AG +
, http://dbpedia.org/resource/Division_of_Carcinogenesis +
, http://dbpedia.org/resource/File:Hsp90.jpg +
, http://dbpedia.org/resource/CuraGen_Corporation +
, http://dbpedia.org/resource/Division_of_Cancer_Treatment_and_Diagnosis +
, http://dbpedia.org/resource/File:TopoTarget_logo.jpg +
, http://dbpedia.org/resource/Pericyte +
, http://dbpedia.org/resource/Mammalian_target_of_rapamycin +
, http://dbpedia.org/resource/Atopic_dermatitis +
, http://dbpedia.org/resource/Apoxis +
, http://dbpedia.org/resource/Biopeople +
, http://dbpedia.org/resource/Orphan_drug +
, http://dbpedia.org/resource/National_Cancer_Institute +
, http://dbpedia.org/resource/Extravasation_%28intravenous%29 +
, http://dbpedia.org/resource/Sweat +
, http://dbpedia.org/resource/Basal_cell_carcinoma +
, http://dbpedia.org/resource/Siramesine +
, http://dbpedia.org/resource/Lung_cancer +
, http://dbpedia.org/resource/Chief_Executive_Officer +
, http://dbpedia.org/resource/Astellas +
, http://dbpedia.org/resource/EDA_%28gene%29 +
, http://dbpedia.org/resource/European_Commission +
, http://dbpedia.org/resource/Medicon_Valley_Alliance +
, http://dbpedia.org/resource/Leukemia +
, http://dbpedia.org/resource/CBS_Interactive +
, http://dbpedia.org/resource/Category:2014_disestablishments_in_Denmark +
, http://dbpedia.org/resource/Colorectal_polyps +
, http://dbpedia.org/resource/Dexrazoxane +
, http://dbpedia.org/resource/Category:Biotechnology_companies_disestablished_in_2014 +
, http://dbpedia.org/resource/LEO_Pharma +
, http://dbpedia.org/resource/Topical_medication +
, http://dbpedia.org/resource/Clinical_trials +
, http://dbpedia.org/resource/PhD +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Malignancies +
, http://dbpedia.org/resource/Chemotherapy +
, http://dbpedia.org/resource/Marketing +
, http://dbpedia.org/resource/FasL +
, http://dbpedia.org/resource/Familial_adenomatous_polyposis +
, http://dbpedia.org/resource/HSP90 +
, http://dbpedia.org/resource/National_Institutes_of_Health +
, http://dbpedia.org/resource/Carboplatin +
, http://dbpedia.org/resource/Breast_cancer +
, http://dbpedia.org/resource/Subcutaneous_tissue +
, http://dbpedia.org/resource/Sigma_receptor +
, http://dbpedia.org/resource/Apoptosis +
, http://dbpedia.org/resource/Actinic_keratosis +
, http://dbpedia.org/resource/Metastases +
, http://dbpedia.org/resource/Switzerland +
, http://dbpedia.org/resource/Rigshospitalet +
, http://dbpedia.org/resource/OMX +
, http://dbpedia.org/resource/Assay +
, http://dbpedia.org/resource/CFO +
, http://dbpedia.org/resource/Biochemical_Journal +
, http://dbpedia.org/resource/Malaria +
, http://dbpedia.org/resource/Melanoma +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2000 +
, http://dbpedia.org/resource/Investor_relations +
, http://dbpedia.org/resource/Psoriasis +
, http://dbpedia.org/resource/Cutaneous_T-cell_lymphoma +
, http://dbpedia.org/resource/Drug_development +
, http://dbpedia.org/resource/Novartis +
, http://dbpedia.org/resource/Head_and_neck_cancers +
, http://dbpedia.org/resource/Category:Danish_companies_established_in_2000 +
, http://dbpedia.org/resource/Immunosuppressive_drug +
, http://dbpedia.org/resource/Tumorigenesis +
, http://dbpedia.org/resource/Cell_proliferation +
, http://dbpedia.org/resource/Tumor +
, http://dbpedia.org/resource/Histone_deacetylase +
, http://dbpedia.org/resource/Europe +
, http://dbpedia.org/resource/Recombinant_fusion_protein +
, http://dbpedia.org/resource/Category:Defunct_companies_based_in_Copenhagen +
, http://dbpedia.org/resource/Category:Cancer_research +
, http://dbpedia.org/resource/John_Wiley_&_Sons +
, http://dbpedia.org/resource/Chairman_of_the_Board +
, http://dbpedia.org/resource/Molecular_Pharmacology +
, http://dbpedia.org/resource/Danish_krone +
, http://dbpedia.org/resource/FDA_Fast_Track_Development_Program +
, http://dbpedia.org/resource/Hematological +
, http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/Doctor_of_Medicine +
, http://dbpedia.org/resource/Nicotinamide_adenine_dinucleotide +
|
http://dbpedia.org/property/assets
|
DKK 585.41 million , p. 24
|
http://dbpedia.org/property/equity
|
DKK 411.79 million , p. 24
|
http://dbpedia.org/property/foundation
|
2000
|
http://dbpedia.org/property/homepage
|
http://www.topotarget.com/ +
|
http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
http://dbpedia.org/property/keyPeople
|
Bo Jesper Hansen
, Peter Buhl Jensen
, Francois Martelet
, Jean-Louis Misset
, Anders Fink Vadsholt
|
http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Denmark +
, http://dbpedia.org/resource/Copenhagen +
|
http://dbpedia.org/property/logo
|
200
|
http://dbpedia.org/property/name
|
TopoTarget
|
http://dbpedia.org/property/netIncome
|
DKK 140.46 million , p. 24
|
http://dbpedia.org/property/numEmployees
|
53
|
http://dbpedia.org/property/operatingIncome
|
DKK 132.49 million , p. 24
|
http://dbpedia.org/property/revenue
|
DKK 43.979 million , p. 24
|
http://dbpedia.org/property/type
|
Public
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Quote +
, http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:Cite_journal +
, http://dbpedia.org/resource/Template:Cite_web +
, http://dbpedia.org/resource/Template:OMX +
, http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:Main +
, http://dbpedia.org/resource/Template:Decrease +
, http://dbpedia.org/resource/Template:As_of +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Infobox_company +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Companies_listed_on_Nasdaq_Copenhagen +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Denmark +
, http://dbpedia.org/resource/Category:Danish_companies_established_in_2000 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_disestablished_in_2014 +
, http://dbpedia.org/resource/Category:Defunct_companies_based_in_Copenhagen +
, http://dbpedia.org/resource/Category:Cancer_research +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2000 +
, http://dbpedia.org/resource/Category:2014_disestablishments_in_Denmark +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/TopoTarget?oldid=1094222004&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/TopoTarget_logo.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Hsp90.jpg +
|
http://xmlns.com/foaf/0.1/homepage
|
http://www.topotarget.com/ +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/TopoTarget +
|
http://xmlns.com/foaf/0.1/name
|
TopoTarget
|
owl:sameAs |
http://dbpedia.org/resource/TopoTarget +
, https://global.dbpedia.org/id/2NiJq +
, http://yago-knowledge.org/resource/TopoTarget +
, http://rdf.freebase.com/ns/m.012697wq +
, http://www.wikidata.org/entity/Q25302593 +
|
rdf:type |
http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInCopenhagen +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn2000 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/ontology/Company +
, http://schema.org/Organization +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfDenmark +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnTheOMXExchanges +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/ontology/Organisation +
|
rdfs:comment |
TopoTarget (Nasdaq Copenhagen: TOPO) was a Copenhagen-based biotechnology company focused on the discovery and development of drugs and therapies to treat cancer. In 2014, it merged with BioAlliance Pharma and is now part of .
|
rdfs:label |
TopoTarget
|